Patricia E. Penovich, MD

Patricia E. Penovich, MD
Minnesota Epilepsy Group, P.A., St. Paul, MN

Karen E. Eck, MS, FNP
Columbia University Neurological Institute, New York, NY

Vasiliki V. Economou, MD
Neurological and Epilepsy Consultants, Hayward, CA

Correspondence: Patricia E. Penovich, MD, Minnesota Epilepsy Group, P.A., 310 Smith Avenue N., Suite 300, St. Paul, MN 55102–2383; e-mail: pep@mnepilepsy.net

Dr. Penovich receives grants/research support from RW Johnson, Pfizer, UCB Pharma, Novartis, GlaxoSmithKline, and Elan; is a consultant for GlaxoSmithKline and Elan; and is on the speakers' bureau for RW Johnson, UCB Pharma, Novartis, Shire, Elan, and GlaxoSmithKline.

Ms. Eck and Dr. Economou have indicated they have nothing to disclose.

Patricia E. Penovich, MD
Minnesota Epilepsy Group, P.A., St. Paul, MN

Karen E. Eck, MS, FNP
Columbia University Neurological Institute, New York, NY

Vasiliki V. Economou, MD
Neurological and Epilepsy Consultants, Hayward, CA

Correspondence: Patricia E. Penovich, MD, Minnesota Epilepsy Group, P.A., 310 Smith Avenue N., Suite 300, St. Paul, MN 55102–2383; e-mail: pep@mnepilepsy.net

Dr. Penovich receives grants/research support from RW Johnson, Pfizer, UCB Pharma, Novartis, GlaxoSmithKline, and Elan; is a consultant for GlaxoSmithKline and Elan; and is on the speakers' bureau for RW Johnson, UCB Pharma, Novartis, Shire, Elan, and GlaxoSmithKline.

Ms. Eck and Dr. Economou have indicated they have nothing to disclose.

Patricia E. Penovich, MD
Minnesota Epilepsy Group, P.A., St. Paul, MN

Karen E. Eck, MS, FNP
Columbia University Neurological Institute, New York, NY

Vasiliki V. Economou, MD
Neurological and Epilepsy Consultants, Hayward, CA

Correspondence: Patricia E. Penovich, MD, Minnesota Epilepsy Group, P.A., 310 Smith Avenue N., Suite 300, St. Paul, MN 55102–2383; e-mail: pep@mnepilepsy.net

Dr. Penovich receives grants/research support from RW Johnson, Pfizer, UCB Pharma, Novartis, GlaxoSmithKline, and Elan; is a consultant for GlaxoSmithKline and Elan; and is on the speakers' bureau for RW Johnson, UCB Pharma, Novartis, Shire, Elan, and GlaxoSmithKline.

Ms. Eck and Dr. Economou have indicated they have nothing to disclose.